Ulm EH - Search Results

1

Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

Rizvi NA, Marshall JL, Ness E, Yoe J, Gill GM, Truglia JA, Loewen GR, Jaunakais D, Ulm EH, Hawkins MJ. Rizvi NA, et al. Among authors: ulm eh. Clin Cancer Res. 1998 Jun;4(6):1437-42. Clin Cancer Res. 1998. PMID: 9626460 Clinical Trial.

2

Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RP Jr. Miller VA, et al. Among authors: ulm eh. Clin Cancer Res. 1996 Mar;2(3):471-5. Clin Cancer Res. 1996. PMID: 9816192 Clinical Trial.

3

A Phase I study of LGD1069 in adults with advanced cancer.

Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, Gill GM, Ulm EH, Geiser R, Jaunakais D, Hawkins MJ. Rizvi NA, et al. Among authors: ulm eh. Clin Cancer Res. 1999 Jul;5(7):1658-64. Clin Cancer Res. 1999. PMID: 10430065 Clinical Trial.

4

9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.

Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, et al. Miller WH Jr, et al. Blood. 1995 Jun 1;85(11):3021-7. Blood. 1995. PMID: 7756637 Free article. Clinical Trial.

5

Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.

Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM. Adamson PC, et al. Among authors: ulm eh. Cancer Res. 1995 Feb 1;55(3):482-5. Cancer Res. 1995. PMID: 7834612

6

Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.

Shirley MA, Bennani YL, Boehm MF, Breau AP, Pathirana C, Ulm EH. Shirley MA, et al. Among authors: ulm eh. Drug Metab Dispos. 1996 Mar;24(3):293-302. Drug Metab Dispos. 1996. PMID: 8820419

7

Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors.

Howell SR, Shirley MA, Grese TA, Neel DA, Wells KE, Ulm EH. Howell SR, et al. Among authors: ulm eh. Drug Metab Dispos. 2001 Jul;29(7):990-8. Drug Metab Dispos. 2001. PMID: 11408365

8

Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.

Howell SR, Shirley MA, Ulm EH. Howell SR, et al. Among authors: ulm eh. Drug Metab Dispos. 1998 Mar;26(3):234-9. Drug Metab Dispos. 1998. PMID: 9492386

9

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.

Vyas KP, Kari PH, Pitzenberger SM, Halpin RA, Ramjit HG, Arison B, Murphy JS, Hoffman WF, Schwartz MS, Ulm EH, et al. Vyas KP, et al. Among authors: ulm eh. Drug Metab Dispos. 1990 Mar-Apr;18(2):203-11. Drug Metab Dispos. 1990. PMID: 1971574

10

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.

Halpin RA, Ulm EH, Till AE, Kari PH, Vyas KP, Hunninghake DB, Duggan DE. Halpin RA, et al. Among authors: ulm eh. Drug Metab Dispos. 1993 Nov-Dec;21(6):1003-11. Drug Metab Dispos. 1993. PMID: 7905377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters